In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Don’t ignore heart attack symptoms, especially while travelling

Outlook is good with prompt treatment

Association for Acute CardioVascular Care
Acute Cardiac Care
Coronary Intervention
Acute Coronary Syndromes

Malaga, Spain – 2 March 2019: Don’t ignore heart attack symptoms while travelling, keep emergency numbers at hand. That’s the main message of a study presented today at Acute Cardiovascular Care 20191 a European Society of Cardiology (ESC) congress. Cardiovascular disease is the leading cause of natural death among people who are travelling, yet, so far, the long-term outlook for those who have a heart attack while on a trip is unknown.

“If you are travelling and experience heart attack symptoms such as pain in the chest, throat, neck, back, stomach or shoulders that lasts for more than 15 minutes, call an ambulance without delay,” said study author Dr Ryota Nishio, of the Department of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.

This observational study included 2,564 patients who had a heart attack and rapid treatment with a stent (percutaneous coronary intervention; PCI) between 1999 and 2015 at Juntendo University Shizuoka Hospital. The hospital is on the Izu peninsula, a popular tourist destination near Mount Fuji, and is the regional centre for PCI.

The researchers compared the demographic and clinical characteristics in residents versus people travelling. Patients were followed up for 16 years and the death rates were compared between groups. Mortality data were collected from medical records, telephone contact, and postal questionnaires. 

A total of 192 patients (7.5%) were travelling at the onset of the heart attack. Patients who were travelling were younger and had a higher prevalence of ST-elevation myocardial infarction (STEMI), a serious type of heart attack in which a major artery supplying blood to the heart is blocked.

The median follow-up period was 5.3 years. Locals had a significantly higher rate of all-cause death (25.4%) compared to non-residents (16.7%; p = 0.0015) but the rate of death from cardiac causes was comparable between groups.

Heart attacks during a trip were associated with a 42% lower risk of long-term all-cause death than those that occurred in residents, after adjusting for age, sex, hypertension, diabetes, dyslipidaemia, chronic kidney disease, current smoking, prior heart attack, Killip class,2 and STEMI (adjusted hazard ratio 0.58; 95% confidence interval 0.38–0.83; p = 0.0020).

“Our study shows that long-term outcomes after a heart attack while travelling can be good if you get prompt treatment,” said Dr Nishio. “It is important that, when you are over the immediate emergency phase, and return home, you see your doctor to find out how you can reduce your risk of a second event by improving your lifestyle and potentially taking preventive medication.”

He continued “We also found that overall, patients were more likely to die during follow-up if they were older, had prior heart attack, or had chronic kidney disease. If you fall into any of these groups or have other risk factors like high blood pressure, smoking or obesity, it is particularly important to make sure you know the emergency number at home and at any travel destination.”

Dr Nishio noted that local patients had a higher rate of non-cardiac death, mainly due to cancer. “This may be because most non-residents were from urban areas where people tend to be more health conscious, actively seek medical advice, and have a greater choice of treatment than in remote areas like the Izu peninsula,” he said. “In addition, having a heart attack while away from home is a traumatic event that may create a lasting impression and greater health awareness when patients return home.”

ENDS

Notes to editor

 Authors: ESC Press Office
Tel: +33 (0)4 8987 2499
Email: press@escardio.org

Follow us on Twitter @ESCardioNews 

The hashtag for the meeting is #acuteCVD19.

 

Sources of funding: None.

Disclosures: None.

 

References and notes

1The abstract ‘Clinical characteristics and long-term outcomes in patients with acute coronary syndrome during the trip’ will be presented during Poster Session 1: Acute Coronary Syndromes – Epidemiology, Prognosis, Outcome on Saturday 2 March at 09:00 to 17:30 CET in the Poster Area.

2The Killip classification is used in heart attack patients to quantify the severity of heart failure and predict 30-day mortality.

 

About the Acute Cardiovascular Care Association

The Acute Cardiovascular Care Association (ACCA) is a branch of the ESC. Its mission is to improve the quality of care and outcomes of patients with acute cardiovascular diseases.

About the Acute Cardiovascular Care congress

Acute Cardiovascular Care is the annual congress of the Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC).


About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

 

Information for journalists attending Acute Cardiovascular Care 2019

Acute Cardiovascular Care 2019 takes place 2 to 4 March at the Palacio de Ferias y Congresos de Malaga (FYCMA) in Malaga, Spain. 

  • To register on-site please bring a valid press card or appropriate letter of assignment with proof of three recent published articles (cardiology or health-related, or referring to a previous ESC Event).
  • Press registration is not available to industry or its public relations representatives, event management, marketing or communications representatives.